MedPath

Visceral fat reduction effect verification test by ingestion of plant extracts -Placebo-controlled, randomized, double-blind, parallel-group comparison study

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000053668
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who take medicines regularly (2) Subjects who have a current history of serious liver disease, kidney disease, gastrointestinal disease, heart disease, respiratory disease, endocrine disease, thyroid disease, adrenal gland disease, or other metabolic disease (excluding transient treatment such as colds) (3) Subjects who have a digestive disease that affects digestion and absorption, or a history of surgery (excluding appendicitis) (4) Subjects who have a history or current medical history of drug dependence or alcoholism (5) Subjects who have been diagnosed with familial hyperlipidemia (6) Subjects who are diagnosed with chronic constipation (7) Subjects who are unable to stop taking health foods and supplements (including foods for specified health uses and foods with functional claims) that may affect this study (8) Subjects who have a habit of drinking excessively (drinking more than 20 g of pure alcohol equivalent per day, at least 4 days a week) (9) Subjects who have a habit of smoking excessively (smokers of 21 cigarettes or more per day) (10) Subjects who are wearing a medical device necessary for life support, such as a cardiac pacemaker, implantable cardioverter defibrillator, or biological information monitor (11) Subjects who have a contagious disease or an injury to the palms or the soles of the feet (12) Subjects who have metal in the CT scan measurement site due to surgery, etc. (13) Subjects who are claustrophobic (14) Subjects who have reported that they are allergic to the ingredient in test foods (15) Subjects who have extremely irregular eating habits, shift workers (excluding daytime shift work), or late-night workers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The measured value of abdominal visceral fat area at 12 weeks after ingestion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath